Author Archives: jdyork

Dr. Hurlbut is a physician and consulting professor in the Department of Neurobiology at Stanford University Medical Center, Stanford, California. After receiving his undergraduate and medical training at Stanford, he completed postdoctoral studies in theology and medical ethics. His primary … Continue reading →

Ms. Noonan is a columnist for the Wall Street Journal where her column, Declarations, has run each week for the past thirteen years. She is the author of eight books on American politics, history, and culture, including the best sellers What I … Continue reading →

Mr. Hemmer joined Fox News Channel (FNC) in August of 2005 and is currently a co-host of FNC’s America’s Newsroom. At FNC, Mr. Hemmer has covered an array of stories from around the world. Most recently, he spent several days reporting … Continue reading →

As Mesoblast’s chief medical officer, Dr. Skerrett oversees the human clinical trial programs. She has been involved in stem cell procurement, manipulation, and transplantation for nearly 20 years. Her areas of expertise include conventional transfusion medicine, immunohematology, apheresis, histocompatibility testing … Continue reading →

Dr. Van Bokkelen is chairman and chief executive officer of Athersys, Inc., a biopharmaceutical company that is focused on developing regenerative medicine therapies to treat significant unmet medical needs. Dr. Van Bokkelen received his Ph.D. degree in genetics from the … Continue reading →

Dr. Zeiher is professor of medicine and board-certified in internal medicine and cardiology. He has served on the faculties of Albert Ludwigs University of Freiburg Germany from 1990 to 1995 as director of interventional cardiology. Since May 1995, Dr. Zeiher … Continue reading →

As one of the leading cardiovascular scientists, Professor Anversa has made numerous substantial contributions to regenerative medicine. He received his M.D. degree at the University of Parma, Italy, and has been a professor of pathology at both New York Medical … Continue reading →

Mr. Tenthoff is a managing director and senior research analyst at Piper Jaffray, a U.S.-based investment bank. Mr. Tenthoff conducts research on equities in the biotechnology industry with a focus on anti-infective and cancer drug discovery, orphan diseases, and cell … Continue reading →

Cardiovascular Stem Cell Therapy Patient On March 27, 2007, Mr. Robinson of Georgia, then 58 years old, suffered a severe heart attack. He felt stabbing pains between his shoulder blades and a scan verified substantial heart muscle damage. Arshed Quyyumi, … Continue reading →